Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
11:45 AM - 12:45 PM ET
Orlando, Florida
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Christyn Edmundson, MD
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Emily D. Clark, DO
Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
Susan Scanland, MSN, CRNP, GNP-BC, CDP
Anthony J. Viera, MD, MPH
Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
Pushpa Narayanaswami, MD, FAAN
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Neelam Goyal, MD
From Resistance to Response: Evolving Strategies in MDD Management
Joseph F. Goldberg, MD
Bridging Gaps in LGMD Care
John Vissing, MD, DMSci
Conrad Weihl, MD, PhD
Integrating Perspectives: The Value of Patient and Caregiver Input
Navigating the LGMD2I/R9 Diagnostic Pathway
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Raman Sankar, MD, PhD
Scott Aaronson, MD
Optimizing VNS Parameters: Keys to Therapeutic Success
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
Epilepsy: Beyond Seizure Impact
New Frontiers in the Treatment of DMD Across the Age Spectrum
Crystal Proud, MD
John Brandsema, MD
Omer Abdul Hamid, MD
Examining Emerging Gut Microbiota Biomarkers for MS
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.